Jubilant Pharmova Limited reported positive results for the first quarter ended June 30, 2024 (Q1 FY2025). Revenue Growth Total income grew by 9% year-over-year (YoY) to Rs. 1,746 crore, driven by: Growth in Ruby-Fill® and new product sales in radiopharmaceuticals. Volume growth in radiopharmacies. Continued momentum in the Allergy Immunotherapy business. Positive performance in CDMO …
On July 19, 2024, Wipro Limited, a top technology services and consulting firm, shared its financial results for the quarter ending June 30, 2024. Highlights of the Results for the Quarter ended June 30, 2024 Gross revenue stood at ₹219.6 billion ($2,635.8 million), marking a 1.1% decrease from the previous quarter and a 3.8% decline …
Paytm, known as One 97 Communications Ltd, recently reported a significant net loss of ₹840 crore for the quarter. This marks a considerable increase from the ₹550 crore loss in the previous quarter and the ₹338 crore loss in the same quarter last year. Despite the widened net loss, Paytm’s share price saw an unexpected …
On July 18, 2024, DP Abhushan Limited, a renowned jewellery company with an 84-year legacy known for its purity, design standards, transparency, and wide product range, announced its financial results for the first quarter of FY25, ending June 30, 2024. The company operates in eight locations across India. Financial Highlights ₹ In crore Q1FY25 Q4FY24 …
Muthoot Microfin Limited has announced a 35 basis points (bps) interest rate cut, the second reduction this year following a 55 bps cut in January. This move lowers the effective lending rate from 23.65% to 23.30%, reflecting the company’s commitment to making financial services more affordable and accessible. Muthoot Microfin has demonstrated significant growth, with …
About Approval Zydus Lifesciences Limited has achieved a significant milestone with the final approval of its New Drug Application (NDA) by the US Food and Drug Administration (USFDA). This paves the way for Zydus to market ZituvimetTM XR, an extended-release tablet combining sitagliptin and metformin hydrochloride, for the treatment of type 2 diabetes in the …
Caplin Steriles Limited (Caplin), a subsidiary of Caplin Point Laboratories Limited, has secured significant approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ephedrine Sulfate Injection USP, 50 mg/mL Single Dose Vial. This generic version is therapeutically equivalent to the reference-listed drug (RLD) AKOVAZ, manufactured by …
India’s state-owned oil companies are accelerating their capital expenditure (capex) plans for the 2024-25 fiscal year. Leading the charge are the Indian Oil Corporation (IOC) and Oil and Natural Gas Corporation (ONGC), which have already spent a significant portion of their annual budgets in the first quarter (Q1). Strong Start to FY25 Indian Oil Corporation …
GPT Infraprojects Limited (GPT), a leading infrastructure construction and engineering company, has secured a significant boost to its order book. The company announced that existing contracts with two prominent clients, the National Highways Authority of India (NHAI) and Eastern Railway, Kolkata, have been enhanced by a combined value of ₹103 crore. This positive development highlights …
Moneyboxx Finance has announced an equity fundraising of ₹271 crore following its board meeting on July 17, 2024. The capital raise includes ₹158 crore through a preferential equity issue and ₹113 crore via equity warrants to both promoters and non-promoters. This funding boost will significantly enhance the company’s capital position and support its expansion plans. …
